Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post Schistosoma japonicum Infection.

Wen Z, Ji X, Tang J, Lin G, Xiao L, Liang C, Wang M, Su F, Ferrandon D, Li Z.

Front Immunol. 2017 Dec 13;8:1808. doi: 10.3389/fimmu.2017.01808. eCollection 2017.

2.

A novel regulatory role for tissue transglutaminase in epithelial-mesenchymal transition in cystic fibrosis.

Nyabam S, Wang Z, Thibault T, Oluseyi A, Basar R, Marshall L, Griffin M.

Biochim Biophys Acta. 2016 Sep;1863(9):2234-44. doi: 10.1016/j.bbamcr.2016.05.012. Epub 2016 May 24.

3.

Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.

Lin CH, Chen J, Zhang Z, Johnson GV, Cooper AJ, Feola J, Bank A, Shein J, Ruotsalainen HJ, Pihlajaniemi TA, Goligorsky MS.

Kidney Int. 2016 Jun;89(6):1281-92. doi: 10.1016/j.kint.2016.01.030. Epub 2016 Apr 14.

4.

Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.

Lee SS, Chen YJ, Tsai CH, Huang FM, Chang YC.

Clin Oral Investig. 2016 Jun;20(5):1029-34. doi: 10.1007/s00784-015-1579-0. Epub 2015 Sep 4.

PMID:
26336810
5.

Tissue Transglutaminase-Regulated Transformed Growth Factor-β1 in the Parasite Links Schistosoma japonicum Infection with Liver Fibrosis.

Tang J, Zhu X, Zhao J, Fung M, Li Y, Gao Z, Yan S, Li X, Ji X, Su F, Li Z.

Mediators Inflamm. 2015;2015:659378. doi: 10.1155/2015/659378. Epub 2015 Jun 23.

6.

Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection.

Tang J, Huang H, Ji X, Zhu X, Li Y, She M, Yan S, Fung M, Li Z.

Mediators Inflamm. 2014;2014:753483. doi: 10.1155/2014/753483. Epub 2014 Jul 3.

7.

Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.

Scarpellini A, Huang L, Burhan I, Schroeder N, Funck M, Johnson TS, Verderio EA.

J Am Soc Nephrol. 2014 May;25(5):1013-27. doi: 10.1681/ASN.2013050563. Epub 2013 Dec 19.

8.

Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.

Olsen KC, Epa AP, Kulkarni AA, Kottmann RM, McCarthy CE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ.

Am J Respir Cell Mol Biol. 2014 Apr;50(4):737-47. doi: 10.1165/rcmb.2013-0092OC.

9.

Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.

Oh K, Park HB, Byoun OJ, Shin DM, Jeong EM, Kim YW, Kim YS, Melino G, Kim IG, Lee DS.

J Exp Med. 2011 Aug 1;208(8):1707-19. doi: 10.1084/jem.20101457. Epub 2011 Jul 11.

10.

Transglutaminase 2 and its role in pulmonary fibrosis.

Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ.

Am J Respir Crit Care Med. 2011 Sep 15;184(6):699-707. doi: 10.1164/rccm.201101-0013OC. Epub 2011 Jun 23.

11.

Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.

Popov Y, Sverdlov DY, Sharma AK, Bhaskar KR, Li S, Freitag TL, Lee J, Dieterich W, Melino G, Schuppan D.

Gastroenterology. 2011 May;140(5):1642-52. doi: 10.1053/j.gastro.2011.01.040. Epub 2011 Jan 26.

12.

Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis.

Daneshpour N, Griffin M, Collighan R, Perrie Y.

J Drug Target. 2011 Sep;19(8):624-31. doi: 10.3109/1061186X.2010.531731. Epub 2010 Nov 11.

PMID:
21067461
13.

Persistent elevated tissue-transglutaminase in cystic fibrosis.

Massie J.

J Paediatr Child Health. 2010 Apr;46(4):210. doi: 10.1111/j.1440-1754.2010.01759.x. No abstract available.

PMID:
20546485
14.

Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase.

D'Argenio G, Amoruso DC, Mazzone G, Vitaglione P, Romano A, Ribecco MT, D'Armiento MR, Mezza E, Morisco F, Fogliano V, Caporaso N.

Dig Liver Dis. 2010 Aug;42(8):571-7. doi: 10.1016/j.dld.2009.11.002. Epub 2009 Dec 8.

PMID:
20004152
15.

Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.

Van Herck JL, Schrijvers DM, De Meyer GR, Martinet W, Van Hove CE, Bult H, Vrints CJ, Herman AG.

J Vasc Res. 2010;47(3):231-40. doi: 10.1159/000255966. Epub 2009 Nov 6.

16.

[Expression of tissue transglutaminase on renal interstitial fibrosis rats and intervention of GBE].

Wang D, Li X, Yu X, Shi Y, Yin L.

Zhongguo Zhong Yao Za Zhi. 2009 May;34(9):1133-6. Chinese.

PMID:
19685752
17.

Transglutaminase 2 and nucleoside diphosphate kinase activity are correlated in epithelial membranes and are abnormal in cystic fibrosis.

Treharne KJ, Giles Best O, Mehta A.

FEBS Lett. 2009 Sep 3;583(17):2789-92. doi: 10.1016/j.febslet.2009.07.026. Epub 2009 Jul 18.

18.

Persistent elevated tissue-transglutaminase in cystic fibrosis.

Hasosah M, Davidson G, Jacobson K.

J Paediatr Child Health. 2009 Apr;45(4):172-3. doi: 10.1111/j.1440-1754.2009.01477.x. No abstract available.

PMID:
19426374
19.

Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.

Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Am J Pathol. 2008 Sep;173(3):631-42. doi: 10.2353/ajpath.2008.080025. Epub 2008 Aug 7.

20.

Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation.

Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D'Apolito M, Pettoello-Mantovani M, Guido S, Ciacci C, Cimmino M, Cexus ON, Londei M, Quaratino S.

J Immunol. 2008 Jun 1;180(11):7697-705.

Supplemental Content

Loading ...
Support Center